|
Dear Members,
Your directors are pleased to present the 34th Annual Report along with
the Audited Financial Statements (Standalone & Consolidated) of your Company for the
financial year ended March 31, 2025 (Financial Year 2024-25). 1) FINANCIAL
RESULTS
The Audited Financial Statements of your Company as on March 31, 2025,
are prepared in accordance with the relevant applicable Indian Accounting Standards
(Ind AS) and Regulation 33 o f the Securities and Exchange Board o f India
(Listing Obligations and Disclosure Requirements) Regulations, 2015, (SEBI LODR
Regulations 2015) and the provisions of the Companies Act, 2013 (Act)
The Company's financial performance (Standalone and Consolidated) for the financial
year ended on March 31, 2025 is summarised below: ( in Lakhs)
| Particulars |
Standalone Basis |
Consolidated Basis |
|
For the year ended March 31 |
For the year ended March 31 |
|
2025 |
2024 |
2025 |
2024 |
| Revenue from Operations |
8388.68 |
5489.56 |
11048.37 |
5628.90 |
| Other Income |
13.65 |
86.56 |
14.40 |
86.56 |
| Total Income |
8402.33 |
5576.12 |
11062.77 |
5715.46 |
Less: Expenditure (other than
Finance cost and Depre) |
8281.95 |
5424.62 |
10640.83 |
5431.72 |
Earnings Before Interest,
Taxes, Depreciation, and Amortization |
203.69 |
437.28 |
421.94 |
283.74 |
| Finance Costs |
36.16 |
35.75 |
108.69 |
49.20 |
Depreciation and Amortization |
47.15 |
41.63 |
169.60 |
41.63 |
| Profit Before Tax (PBT) |
120.38 |
151.50 |
143.65 |
192.91 |
| Tax Expense |
47.59 |
36.24 |
50.61 |
55.21 |
| Net Profit |
72.79 |
115.26 |
93.04 |
137.70 |
COMPANY'S PERFORMANCE: STANDALONE OPERATIONS
Total Revenue from Operations increased by 52.81 % to Rs. 8388.68 Lakhs
against Rs.5489.56 Lakhs of the previous year. Earnings before interest tax depreciation
and amortisation (EBITDA) decreased by 53.42 % to Rs.203.69 Lakhs against Rs. 437.28 Lakhs
of the previous year. Profit Before Tax (PBT) decreased by 20.54 % to Rs.120.38 Lakhs
against Rs.151.50 Lakhs of the previous year. Net Profit decreased by 36.85 % to Rs. 72.79
Lakhs against Rs. 115.26 Lakhs of the previous year
CONSOLIDATED OPERATIONS
Total Revenue from Operations increased by 96.28 % to Rs. 11048.37
Lakhs against Rs. 5628.90 Lakhs of the previous year. Earnings before interest tax
depreciation and amortisation (EBITDA) increased by 48.70 % to Rs.421.94 Lakhs against Rs.
283.74 Lakhs of the previous year. Profit Before Tax (PBT) Decreased by 25.54 % to Rs.
143.65 Lakhs against Rs. 192.91 Lakhs of the previous year. Net Profit Decreased by 32.43
% to Rs. 93.04 Lakhs against Rs.137.69 Lakhs of the previous year.
2) AMOUNT TRANSFERRED TO RESERVES
The Board of Directors of your Company has decided not to transfer any
amount to the General Reserve for the year under review. 3) SHARE CAPITAL
Authorised Share capital
During the year under review, there is no change in the Authorised
share capital of the Company. The Authorised share capital of the company is Rs.
387,00,00,000/- divided into 387,00,00,000 Equity Shares having face value of 1/- each..
Issued, Paid up and subscribed Share Capital
The Company had issued Foreign Currency Convertible Bonds (FCCB) in the
financial year 2022-23 and during the financial year 2024-2025 the Company has converted
370 bonds into 4,35,79,475 shares therefore paid-up share capital o f the Company has
increased from 70,80,12,805/- to Rs. 1,87,73,28,995/- in during the period under review
financial year (2024-2025). The current issued, Paid up and subscribed share capital of
the Company is Rs. 1,87,73,28,995/- divided into 187,73,28,995 Equity Shares having face
value of 1/- each 4) PREFRENTIAL ISSUE
During the year, the members of the company had passed Special
resolution on October 23,2024 and issued 24,00,00,000 Convertible Equity Warrants at a
price of Rs. 3.60/- per Warrant, convertible into, or exchangeable for, 1 (one) fully
paid-up equity share of the Company having face value of Re.1/- (Rupee One Only) each at a
premium of Rs. 2.60/- per share to the Promoter group of the Company i.e 12,00,00,000
Warrants to Shree Saibaba Exim Private Limited and 12,00,00,000 Warrants to Raghuvir
International Private Limited. The said warrants are yet to convert into the equity
shares. 5) DIVIDEND
Your director feel that it is prudent to plough back the profits of the
Company for future growth of the Company and therefore do not recommend any dividend for
the year ended March 31, 2025. 6) DEPOSITS
The Company has neither accepted nor renewed any deposits falling
within the purview of Section 73 of the Companies Act, 2013 read with Companies
(Acceptance of Deposits) Rules, 2014 as amended from time to time, during the year under
review and therefore details mentioned in
Rule 8(5)(v)& (vi) of Companies (Accounts) Rules, 2014 relating to
deposits, covered under Chapter V of the Act is not required to be given. 7) PARTICULARS
OF LOANS, GUARANTEES OR INVESTMENTS
Pursuant to the provisions of section 186 of the Companies Act, 2013,
the Company has not given guarantees, however the company has made Loans as detailed in
note no. 4 of Financial Statement of the company and made investment as detailed in note
no. 3 of Financial Statement of the company which are within the limits of Section 186 of
the Act 8) INSURANCE
The Company has a broad-banded approach towards insurance. Adequate
cover has been taken for all movable and immovable assets against numerous risks and
hazards. 9) ANNUAL SECRETARIAL COMPLIANCE REPORT
The Company has undertaken an audit for the Financial Year 2024-25 for
all applicable compliances as per SEBI Regulations and Circulars/Guidelines issued
thereunder. The Annual Secretarial Compliance Report duly signed by M/s. Brajesh Gupta
& Co, Practising Company Secretaries has been submitted to the Stock Exchanges. 10)
MANAGEMENT DISCUSSION AND ANALYSIS
The Management Discussion and Analysis Report as required under
Regulation 34 read with Schedule V of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations,
2015) forms part of this Annual Report. The said comments are disclosed in
Annexure-A. 11) DIRECTORS & KMP
As of March 31, 2025, your Company's (Board) had Five
Directors comprising of 1 Executive Director and 4 Non-Executive Directors out of which 3
Directors are Independent Directors. The details of Board and Committees composition,
tenure of Directors, areas of expertise and other details are available in the Corporate
Governance Report, which forms part of this Annual Report. The Board consists of following
Directors as on the date of this report:
| Sr.no Name of Director |
Designation |
| 1 Mr. Jayesh Raichandbhai Thakkar (DIN:
01631093 ) |
Chairman and Managing |
|
Director |
| 2 Ms. Krupalibahen Rajeshbhai Mehta (DIN:
11109785 ) |
Non-Executive |
|
Independent Director |
|
(w.e.f 30.05.2025) |
| 3 Mr. Kartik Kumar Bakulchandra
Mistry(DIN: 07791008) |
Non-Executive |
|
Independent Director |
| 4 Mr. Hasmukhbhai Dhanjibhai Thakkar (DIN:
07183270 ) |
Non-Executive Director |
| 5 Mr. Parth Patel (DIN: 10345128) |
Non-Executive |
|
Independent Director |
| 6 Mr. Mohammadraza Makrani (DIN: 10335547) |
Non-Executive |
|
Independent Director |
Details of Key Managerial Personnel:
| Sr.no. Name of Director |
Designation |
| 1 Mr. Jayesh Raichandbhai Thakkar |
Managing Director |
| 2 Bhavesh Desai |
Chief Financial Officer |
12) CHANGES IN DIRECTOR
During the year, Ms. Payal Gajjar (DIN: 08745777) vide her letter dated
January 07, 2025 has submitted her resignation as an Independent Director of the company
with effect from the closing of business hours on January 07, 2025 due to her other
professional commitments.
Further, Mr. Parth Patel & Mr. Mohammadraza Makrani were appointed
as Additional Director in the category of Independent Director in the Board Meeting held
on February 09, 2024. The regularisation of their appointment was done by the members of
the Company through Postal ballot on May 05, 2024 (deemed date of passing the resolution
by postal Ballot). After the end of the Financial year, the Board of Directors in their
meeting held on May 30, 2025 has appointed Ms. Krupalibahen Mehta (DIN: 11109785 ) as an
Additional Director in the category of Non-Executive -Independent Director and has been
regularised by passing a special resolution through Postal ballot on August 23, 2025
(deemed date of passing the resolution by postal Ballot).
13) RE-APPOINTMENT OF DIRECTORS WHO RETIRES BY ROTATION
In accordance with the provisions of Section 152 of the Act, read with
rules made thereunder and Articles of Association of the Company, Mr. Jayesh Raichandbhai
Thakkar (DIN:01631093) is liable to retire by rotation at the ensuing Annual General
Meeting (AGM) and being eligible, offers himself for re-appointment.
14) DECLARATION FROM INDEPENDENT DIRECTORS
Pursuant to the provisions of Section 149 of the Companies Act, 2013,
the Independent Directors have submitted declarations that each of them meets the criteria
of independence as provided in Section 149(6) of the Act along with Rules framed
thereunder and Regulation 16(1)(b) of the SEBI (LODR) Regulations, 2015. There has been no
change in the circumstances affecting their status of Independent Directors of the
Company.
Independent Director of the Company has provided declarations under
Section 149 (7) of the Companies Act, 2013 and Regulation 25 (8) of Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,
2015, that he/she meets with the criteria of independence, as prescribed under Section 149
(6) of the Companies Act, 2013 and Regulation 16 (1) (b) of Securities and Exchange Board
of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
15) COMMITTEES OF BOARD
Details of various committees constituted by the Board, including the
committees mandated pursuant to the applicable provisions of the Companies Act, 2013 and
SEBI (LODR) Regulations, 2015, are given in the Corporate Governance Report, which forms
part of this Annual Report.
16) BOARD EVALUATION
The Board of Directors were required to carry out an annual evaluation
of its own performance, board committees, and individual directors pursuant to the
provisions of the Act and SEBI Listing Regulations. Based on the guidance note on Board
Evaluation issued by the Securities and Exchange Board of India, a structured
questionnaire was prepared after taking into consideration the various aspects of the
Board's functioning, composition of the Board and its Committees, culture, execution
and performance of specific duties, obligations and governance. In a separate meeting of
Independent Directors, the performance of Non-Independent Directors, the board as a whole
and the Chairman of the Company was evaluated, taking into account the views of Executive
Directors and Non-executive Directors. The Board and the Nomination and Remuneration
Committee reviewed the performance of individual directors on the basis of criteria such
as the contribution of the individual director to the board and committee meetings like
preparedness on the issues to be discussed, meaningful and constructive contribution and
inputs in meetings, etc. In the Board meeting that followed the meeting of the independent
directors and meeting of the Nomination and Remuneration Committee, the performance of the
Board, its committees, and Individual Directors was also discussed. Performance evaluation
of Independent Directors was done by the entire board, excluding the Independent Director
being evaluated.
17) DIRECTORS RESPONSIBILITY STATEMENT
Pursuant to Section 134(5) of the Companies Act, 2013 the Board, to the
best of their knowledge and based on the information and explanations received from your
Company, confirm that: In the preparation of the annual financial statements, the
applicable accounting standards have been followed and there are no material departures.
1.Such accounting policies have been selected and applied consistently and judgement and
estimates have been made that are reasonable and prudent so as to give a true and fair
view of the state of affairs of the Company as at March 31, 2025 and of the profit of the
Company for the year ended on that date; 2.Proper and sufficient care has been taken for
the maintenance of adequate accounting records in accordance with the provisions of the
Companies Act, 2013 for safeguarding the assets of the Company and for preventing and
detecting fraud and other irregularities; 3.The annual financial statements have been
prepared on a going concern basis; 4. Proper internal financial controls were in place and
that the financial controls were adequate and were operating effectively; 5. Proper
systems to ensure compliance with the provisions of all applicable laws were in place and
were adequate and operating effectively.
18) CORPORATE SOCIAL RESPONSIBILITY (CSR)
As per section 135 of Companies Act 2013, Corporate Social
Responsibility is applicable to Companies having;
1. Turnover of Rupees 1000 Crore or more, or
2. Having Net Worth of Rupees 500 Crore or more, or
3. Having Net Profit of Rupees 5 Crore or more.
The Company does not fulfil any of the above criteria therefore
provisions related to Corporate Social Responsibility doesn't apply to Evexia
Lifecare Limited.
19) DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE
(PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013.
The Company has zero tolerance with respect to Sexual Harassment at
workplace. To this end, the Company has adopted the Prevention of Sexual Harassment
(POSH) policy to provide a safe, secure and enabling environment, free from
sexual harassment. The Policy is gender neutral and the framework ensures complete
anonymity and confidentiality. All employees (permanent, contractual, temporary, trainees)
as defined under the POSH Act are covered in this Policy. The Company has set up an
Internal Complaints (IC) Committee in compliance with the Women at Workplace
(Prevention, Prohibition & Redressal) Act, 2013 (POSH Act), to redress
complaints received regarding sexual harassment The POSH Policy of the Company is
published on website of the company. The status of complaints received under POSH and
redressed by the Company, during financial year 2024-25, are given below: There was no
complaint outstanding / received from any employee during the financial year 2024-25 and
hence, no complaint is pending as on March 31, 2025 for Redressal. (a) Number of
complaints received during the financial year 2024-25 0 (b) Number of complaints resolved
during the financial year 2024-25 0 (c) Number of complaints pending for resolution as at
the end of the financial year 2024-25-0
20) CORPORATE GOVERNANCE REPORT
The Report on Corporate Governance as required under Regulation 34 read
with Schedule V of the SEBI (LODR) Regulations, 2015, forms part of this Annual Report as
Annexure-B. The certificate from Practicing Company Secretaries required as per the
aforesaid Schedule V, confirming compliance with the conditions of Corporate Governance as
stipulated under the SEBI (LODR) Regulations, 2015 is attached to the Report on Corporate
Governance.
21) BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT
According to Regulation 34(2)(f) of SEBI (LODR) Regulations, 2015,
Business Responsibility and Sustainability Report is mandatory for Top 1000 Listed
Companies according to Market Capitalization. Evexia Lifecare Limited doesn't fulfil
the above criteria therefore Business Responsibility and Sustainability Report is not
applicable to the company.
22) ANNUAL RETURN
Pursuant to Section 134(3)(a) of the Companies Act 2013, the draft
annual return as on 31st March, 2025 prepared in accordance with Section 92(3) of the Act
is made available on the website of your Company.
23) TRANSACTIONS WITH RELATED PARTY
During the financial year 2024-25, there have been no material
significant related party transactions that may have potential conflict with the interest
of the Company at large. Further Company did not enter into any material contracts or
arrangements with related parties in terms of Section 188(i) of the Companies Act, 2013.
Accordingly, the disclosure of related party transactions as required
under Section 134(3)(h) of the Companies Act, 2013 in Form AOC-2 is not applicable to the
company for FY 2024-25 and hence does not form part of this Annual Report. However, the
Company submits details of other related party transactions as required in the notes to
the standalone financial statements.
24) PARTICULARS OF VALUATION DONE AT THE TIME OF ONE-TIME SETTLEMENT
AND VALUATION DONE WHILE TAKING LOAN FROM THE BANKS OR FINANCIAL INSTITUTIONS
During the Financial period under review, there were no instances of
any one-time settlement against loans taken from Banks or Financial Institutions.
25) INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY : Company has effective
internal control and risk-mitigation system, which are constantly assessed and
strengthened with new/ revised standard operating procedures. The Company's internal
control system is commensurate with its size, scale and complexities of its operations.
Our management assessed the effectiveness of the Company's internal control over
financial reporting (as defined in Regulation 17 of SEBI (Listing Obligation and
Disclosure Requirements) Regulations, 2015) as of March 31st, 2025. The internal control
system provides for all documented policies, guidelines, authorization and approval
procedures.
The statutory auditors while conducting the statutory audit, review and
evaluate the internal controls and their observations are discussed with the Audit
Committee of the Board. Further the Company has in place adequate Internal Financial
Controls with reference to financial statements. During the year, such controls were
tested and no reportable material weakness in the design or operations were observed.
26) SEBI COMPLAINTS REDRESS SYSTEM (SCORES) : The investor complaints
are processed in a centralised web-based complaints redress system. The salient features
of this system are: Centralised database of all complaints, online upload of Action Taken
Reports (ATRs) by concerned companies and online viewing by investors of actions taken on
the complaint and its current status.
27) DISPUTE RESOLUTION MECHANISM (SMART ODR): In order to strengthen
the dispute resolution mechanism for all disputes between a listed company and/or
registrars & transfer agents and its shareholder(s)/investor(s), SEBI had issued a
Standard Operating Procedure ('SOP') vide Circular dated 30 May 2022. As per this
Circular, shareholder(s)/ investor(s) can opt for Stock Exchange Arbitration Mechanism for
resolution of their disputes against the Company or its RTA. Further, SEBI vide Circular
dated 31 July 2023 (updated as on 20 December 2023), introduced the Online Dispute
Resolution (ODR) Portal. Through this ODR portal, the aggrieved party can initiate the
mechanism, after exercising the primary options to resolve its issue, directly with the
Company and through the SEBI Complaint Redress System (SCORES) platform. The Company has
complied with the above circulars and the same are available at the website of the
Company.
28) AUDITORS & THEIR REPORT:
Pursuant to Section 139 of the Companies Act, 2013 read with rules made
thereunder, as amended, M/s. M. A. Shah & Co., Chartered Accountants (FRN No-
0112630W), were appointed as the Statutory Auditors of your Company in Financial Year
2024-2025 due to casual Vacancy occurred due to Resignation of M/s .Tejas K. Soni &
Company, Chartered Accountants (FRN No- 135093W). The Statutory Auditors have confirmed
that they are not disqualified to continue as Statutory Auditors and are eligible to hold
office as Statutory Auditors of your Company.
The Notes to the financial statements referred in the Auditors Report
are self-explanatory. The Auditors Report is enclosed with the financial statements
forming part of this Annual Report. Explanation to Auditors Adverse Opinion
| Sr.no Qualification |
Management's response |
| 1 We draw attention to Note 2 to the
financial statements, which indicates that the Company has not maintained a proper fixed
asset register showing details of location, quantity, and identification codes for its
Property, Plant and Equipment (PPE). Several fixed assets have exceeded their prescribed
useful life under Schedule II of the Companies Act, 2013, but depreciation continues to be
charged without any assessment o f residual value or technical revalidation. Further, the
carrying amount of assets as at 31 March 2025 docs not reconcile with the balances
reported in the prior year's audited financial statements. In the absence o f appropriate
records and reconciliations, we are unable to verify the accuracy of depreciation charged
and the completeness and valuation o f PPE disclosed in the financial statements. |
The Company acknowledges the observation
regarding the maintenance of the fixed asset register. Management is in the process of
reconstructing and updating the fixed asset records, including location, quantity, and
identification details. |
|
Further, a comprehensive technical
assessment o f assets that h ave exceeded their u seful life u n d er Schedule II is b
eing initiated to determine appropriate residual values and revised useful lives, wherever
applicable. |
|
Reconciliation of carrying values with
prior year audited financial statements is also u n d erway, and n ecessary adjustments,
if any, will b e incorporated in subsequent financial reporting periods. |
| 2 We draw attention to Note 3 to the
financial statements, which indicates that the Company holds investments in subsidiaries
and other companies and revival pans in certain amounting to 70,880.85 lakh. These
investee companies are incurring losses and, in some cases, have ceased operations. The
Company has not performed an impairment assessment of these investments as required under
Ind AS 36 "Impairment of Assets" and has neither determined the fair value of
these investments as required by Ind AS 109 "Financial Instruments" nor provided
adequate justification for continued recognition at cost. Consequently, we are unable to
determine whether any impairment provision is required in the financial statements and the
impact of the same on the reported profit and net worth of the Company. |
The management is aware o f the
requirements under Ind AS 36 and Ind AS 109. Due to ongoing restructuring subsidiaries,
the Company h as continued to carry investments at cost. |
|
However, the Company has initiated an
independent valuation and impairment assessment exercise. Based on the outcome,
appropriate impairment provisions, if required, will b e recognized in the subsequent
financial statements. |
| 3 We draw attention to Note 8 to the
financial statements, which indicates that trade receivables amount to 8,745.95 lakh, of
which approximately 4,206.12 lakh (48%) are outstanding for a period exceeding three
years. The Company has not recognised expected credit loss (ECL) on these overdue balances
as required under Ind AS 109, and management has not provided sufficient evidence
regarding their recoverability. In the absence of corroborative documentation such as
confirmations, subsequent collections, or legal recoveries, we are unable to comment on
the recoverability of the said balances and the adequacy o f the provision required, if
any. |
The Company is actively pursuing recovery
o f long-outstanding receivables through negotiations, legal actions, and follow-ups. |
|
An exercise to o b tain b alance
confirmations and assess recoverability is currently in progress. The Company is also in
the process of implementing an Expected Credit Loss (ECL) model in line with Ind AS 109,
and necessary provisions will be accounted for based on the assessment. |
| 4 We draw attention to Note 15 to the
financial statements, which indicates that the Company continues to account for Foreign
Currency Convertible Bonds (FCCBs) issued during the previous years at historical cost.
The FCCBs have neither been recognised at amortised cost in accordance with Ind AS 109
"Financial Instruments" nor revalued under Ind AS 21 "The Effects of
Changes in Foreign Exchange Rates". The Company has also not accounted for the equity
conversion feature embedded in the FCCBs as a separate component under Ind AS 32
"Financial Instruments: Presentation". In the absence of necessary workings and
management's fair valuation, we are unable to comment on the consequential impact o f
these o missions o n Statement of Profit and Loss and Other Equity. |
The Company acknowledges that FCCBs need
to be accounted for in accordance with Ind AS 109, Ind AS 21, and Ind AS 32. Due to
complexity in v aluation and restructuring discussions with bondholders, the same has been
continued at historical cost. the |
| 5 We draw attention to Note 17 to the
financial statements. The Company has disclosed trade payables of 5,446.53 lakh, against
which available cash and cash equivalents stand at 2.92 lakh as on 31 March 2025. A
significant portion of these trade payables are aged beyond three years and are not
supported by recent transactions o r confirmations. The Company has not made any
disclosures under Ind AS 107 "Financial Instruments: Disclosures" with respect
to liquidity risk or aging analysis of financial liabilities. We are therefore unable to
ascertain the correctness of these balances and whether the Company has appropriately
discharged its o bligations in a timely manner. |
The Company is in the process of
reconciling aged trade payables and obtaining confirmations from creditors. Certain b
alances relate to legacy transactions and are under review for settlement o r write-back,
as appropriate. |
|
The Company is also working towards
strengthening its liquidity p o sition through restructuring of operations and infusion of
funds. Required disclosures under Ind AS 107, including aging and liquidity risk, will be
made in future financial statements. |
| 6 We draw attention to Notes 4 and 15 of
the financial statements, which indicates that the Company has granted loans to
subsidiaries, associates, and o thers aggregating 4,994.18 lakh and has received
borrowings from related parties aggregating 736.32 lakh. These loans are interest-free and
do not have clearly defined repayment terms. The absence of agreement terms and
non-recognition of interest income and expense are not in compliance with Ind AS 109 and
may be prejudicial to the interest of shareholders. |
The loans extended and borrowings received
are p rimarily strategic in nature to support group entities. The Company acknowledges
that formal agreements and fair valuation are required under Ind AS 109 and Ind |
|
AS 24. The management is in the process of
formalizing terms, documenting agreements, and computing n o tional interest for
appropriate recognition and disclosure in subsequent periods. |
| Further, the Company has not provided fair
valuation or appropriate disclosures under Ind AS 24 "Related Party
Disclosures". |
|
| 7 The Company and its subsidiaries have
incurred significant penalties under income tax, GST, and SEBI regulations. These have not
been adequately disclosed or accounted for, potentially violating Section 134(3)(q) and
Rule 8(5)(vii) of the Companies (Accounts) Rules, 2014. |
The Company acknowledges the observation
and confirms that a detailed review o f p enalties u n d er Income Tax, GST, and SEBI
regulations is being conducted. |
| 8 The Company has not maintained adequate
documentation for tax expense recognition. Several prior period tax liabilities and
refunds have been recognised o r adjusted through the Statement of Profit and Loss during
the year without supporting workings or tax assessments. The Company has also not
recognised deferred tax assets o r liabilities as required by Ind AS 12 "Income
Taxes", citing absence of reliable estimates. In the absence o f an appropriate tax
computation and reconciliation statement, we are unable to determine the completeness and
correctness o f tax provisions and disclosures. |
Appropriate d isclosures and accounting
treatment will be ensured in compliance with applicable provisions of the Companies Act, 2
0 1 3 and relevant rules going forward. The Company is in the process of preparing
detailed tax computations, including reconciliation of prior period adjustments. |
|
Due to uncertainties in taxable income and
timing differences, deferred tax assets/liabilities were not recognized. |
|
However, the Company is undertaking a
comprehensive assessment in line with Ind AS 1 2 , and appropriate recognition and
disclosures will be made in future financial statements. |
II SECRETARIAL AUDIT & COMPLIANCE REPORT
Pursuant to the provisions of Section 204 of the Companies Act 2013,
read with the rules made thereunder, the Board had appointed Mr. BRAJESH GUPTA & CO,
Practicing Company Secretary, to undertake the Secretarial Audit of your Company for the
FY 2024-25. The Secretarial Audit Report for the year under review is provided as
Annexure-C of this report. The qualifications, reservations or adverse remarks mentioned
in the said report along with the response provided by the Management are as follows:
| Sr.no Qualification |
Management's Response |
| 1 The Company has made delay in submission
of its Consolidated Financial Statements along with Audit Report for the quarter ended
30.09.2024, by 1 day, and violated the provision of Regulation 33 of the SEBI (LODR)
Regulations, 2015. |
The Management informed that the mistake
was inadvertent in nature and Company will be more cautious in future while complying
applicable SEBI (LODR) Regulation 2015. The Company has paid fine Imposed by BSE. |
| 2 The Company has made delay in submission
of Annual Secretarial Compliance Report under Regulation 24A of SEBI (LODR), Regulations,
2015 with 1 day. The BSE Limited has imposed a fine of Rs. 4,000 for said non-compliance. |
The Management informed that the mistake
was inadvertent in nature and Company will be more cautious in future while complying
applicable SEBI (LODR) Regulation 2015. The Company has paid fine Imposed by BSE. |
| 3 The Company has converted 20 bonds on
01.04.2024, 75 bonds on 17.06.2024, 25 bonds on 26.07.2024, 100 bonds on 25.09.2024 and
150 on 12.10.2024 into equity shares as per the terms and conditions of the issue of FCCB
in the Board Meetings Held during the Financial Year 2024- 2025 which are resulting in a
change exceeding 2% of the total paid-up share capital. However, the Company has not
complied the requirement under Regulation 31(1)(c) of SEBI (LODR), Regulations, 2015 for
such capital restructuring. |
The Management clarified that due to
unavailability of qualified Company Secretary the Company could not submit the Compliance
requirement within time limit specified under SEBI (LODR), Regulations, 2015 |
| 4 100% (Hundred percent) shareholding of
promoter(s) and promoter group are not in dematerialized form as per Regulation 31(2) of
SEBI (LODR) Regulations, 2015. |
The Management clarified that the
shareholding of the concerned Promoters whose shareholding are yet to be dematerialized
have confirmed to initiate the process o f converting their shares into demat form. |
| 5 The Company has made delay in submission
of disclosure o f related party transactions under Regulation 23(9) of SEBI (LODR)
Regulations, 2015 for period ended September, 2024 of 24 days. Further, BSE Limited has
Imposed a fine o f Rs.1,29,800/- on the Company for the same. |
The Management clarified that due to
unavailability of whole-time Company Secretary the Company could not submit the Compliance
requirement within stipulated period as said regulation. The Company has paid the fine
impose by BSE. |
| 6 The Company has failed to comply with
Section 186 o f the Companies Act, 2013 and made Investment, loan, guarantee or security
given by the Board, exceeding the limits approved by the members of the Company on
February 05, 2018. |
The Management clarified that the Company
has taken corrective steps to regularize the transaction and in process of obtaining
approval of the shareholders through a special resolution, as applicable. |
| 7 The Company has granted loan(s) in
connection with loan(s) to person(s)/entity (ies) covered under section 185 of the Act
without obtaining prior approval o f shareholders by way o f a special resolution. Hence,
the Company has not complied with the provisions of Section 185 o f the Companies Act,
2013 to that extent. |
The Management clarified that the Company
has taken corrective steps to regularize the transaction and in process of obtaining
approval of the shareholders through a special resolution, as applicable. |
III COST AUDITOR
The provision of the section 148 of the Companies Act, 2013 read with
Rules 14 of the Companies (Audit & Auditors) rules, 2014 is not applicable to the
company. 29) INTERNAL AUDITOR
The Board of Directors has on the recommendation of Audit Committee,
and pursuant to the provision of Section138 of the Companies Act 2013, has appointed M/s
Shital Samriya, as an Internal Auditor of the Company. 30) SECRETARIAL STANDARDS
During the year under review, your Company has complied with all the
applicable provisions of Secretarial Standard-1 and Secretarial Standard-2 issued by the
Institute o f Company Secretaries of India.
31) INVESTOR EDUCATION AND PROTECTION FUND (IEPF) Since there was no
unpaid/unclaimed Dividend declared and paid in previous year, the provisions of Section
125 of the Companies Act, 2013 is not applicable to the Company.
32) DETAILS OF APPLICATION MADE OR ANY PROCEEDING PENDING UNDER
INSOLVENCY AND BANKRUPTCY CODE, 2016. During the year under Review, neither any
application was made, nor any proceedings were pending under Insolvency and Bankruptcy
Code, 2016.
33) VIGIL MECHANISM/WHISTLE BLOWER POLICY : Pursuant to the provisions
of Section 177(9) & (10) of the Companies Act, 2013 and Regulation 22 of the SEBI
(LODR) Regulations, 2015, a Vigil Mechanism/Whistle Blower Policy for directors, employees
and other stakeholders to report genuine concerns has been established. The same is
uploaded on the website of the Company.
34) CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE
EARNINGS AND OUTGO
Information related to conservation of energy, research and
development, technology absorption, foreign exchange earnings and outgo as required under
Section 134(3)(m) of the Companies Act, 2013 and Rule 8(3) of Companies (Accounts) Rules,
2014 is annexed herewith as Annexure-D and forms a part of this Report.
35) CODE OF CONDUCT
In compliance with the requirements of Regulation 17(5) of the SEBI
Listing Regulations, the Board of Directors has laid down Code of Conduct for all Board
Members and Senior Management of the Company. This code is also posted o n the website o f
the Company at https://www.evexialifecare.com/policies-cg/Code%20of%20Conduct.pdf
36) MATERIAL ORDERS PASSED BY REGULATORY/COURT
There were no significant and material orders passed by any regulators
and/or courts and tribunals which may have the impact on the going concern status and
company's operations in future.
37) FRAUD REPORTING
No fraud has been reported by the auditor under Section 143(12) of the
Act to the Audit Committee of the Board.
38) CODE FOR PREVENTION OF INSIDER TRADING:
In accordance with the Securities and Exchange Board of India
(Prohibition of Insider Trading) Regulations, 2015, your company has implemented a Code of
Conduct to control, oversee, and report trading by designated individuals and their close
family members ("Code"). Among other things, the Code specifies the protocols
that designated individuals must adhere to while trading or dealing in the Company's
shares and disclosing Unpublished Price Sensitive Information ("UPSI"). The Code
addresses the company's responsibility to keep a structured digital database
("SDD"), the procedures for handling UPSI and preventing insider trading, and
the process for becoming acquainted with the sensitivity of UPSI.
39) MANAGERIAL REMUNERATION
Disclosures pursuant to Section 197(12) of The Companies Act, 2013 read
with Rule 5(1), 5(2) and 5(3) of The Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014 are enclosed herewith as per Annexure-E.
40) SUBSIDIARIES, JOINT VENTURES, ASSOCIATE COMPANIES AND LLP ETC.
The Company has unlisted Subsidiaries and Associate Companies , details
of which are as mentioned below, the company doesn't have any Joint Venture during
the year. Details of Subsidiary Company, Associate Companies and LLP's.
| Kavit Edible Oil Limited |
| Kavit Trading Private Limited |
| Evexia Lifecare Africa Limited |
| Diponed Research International Private Limited |
| Diponed Bio Private Limited |
| Vittals Medicare Private Limited |
| Evexia PAN Africa Limited (Step Down Subsidiary) |
| Heemsol Energy System Private Limited (Associate Company) |
A statement containing the salient features of financial statement of
our subsidiaries in the prescribed format AOC-1 is attached herewith Annexure
F
41) RISK MANAGEMENT
The Company has formulated Risk Management Committee constituted by the
Board of Directors comprising of 3 Directors. The Company has created a risk management
policy that includes the components of different Risk as well as an execution plan to
lessen those risks. The Board reviews the risk management framework on a regular basis.
42) POLICY ON DIRECTORS' APPOINTMENT & REMUNERATION
The Company's policy on Directors' appointment and
remuneration including criteria for determining qualifications, positive attributes,
independence of a Director and other matters provided in Section 178(3) and Section
134(3)(e) o f the Act is available at
https://www.evexialifecare.com/policies-cg/criteria%20of%20making%20payments%20to%20non-executive%20directors.pdf
44) DIRECTORS & OFFICERS LIABILITY INSURANCE
According to Regulation 25(10) of SEBI (LODR) Regulations, 2015,
Directors & Officers Liability Insurance is mandatory for Top 1000 Listed Companies
according to Market Capitalization. Evexia Lifecare Limited doesn't fulfil the above
criteria therefore Business Responsibility and Sustainability Report is not applicable to
the company.
43) AUDIT COMMITTEE: The details pertaining to the composition of the
audit committee are given in the report on corporate governance forming part of this
Report. Further, all the recommendations made by the audit committee were accepted by the
Board.
44) CHANGE(S) IN THE NATURE OF BUSINESS:
There was no change in the nature of business of the Company during the
FY ended March 31, 2025.
45) MATERIAL CHANGES AFTER END OF FINANCIAL YEAR: There has been no
material change and commitment, affecting the financial performance of the Company which
occurred between the end of the Financial Year of the Company to which the financial
statements relate and the date of this Report.
ACKNOWLEDGMENT
Your Directors wish to place on record their appreciation for the
continued support and cooperation of the shareholders, banks, various regulatory and
government authorities and for the valuable contributions made by the employees of the
Company. For and On Behalf of Board of Directors
EVEXIA LIFECARE LIMITED
| Jayesh Raichandbhai Thakkar |
Place- Vadodara |
| Chairman and Managing Director |
|
| (DIN - 01631093) |
Date- 22/04/2026 |
|